Drug Profile
Nic 12
Alternative Names: Nic-12Latest Information Update: 28 Jan 2020
Price :
$50
*
At a glance
- Originator APeT
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Attention-deficit hyperactivity disorder; Autistic disorder
Most Recent Events
- 28 Jan 2020 No recent reports of development identified for clinical-Phase-Unknown development in Attention-deficit-hyperactivity-disorder in Netherlands (PO, Controlled release)
- 28 Jan 2020 No recent reports of development identified for clinical-Phase-Unknown development in Autistic-disorder in Netherlands (PO, Controlled release)
- 13 Dec 2016 Clinical trials in Attention-deficit hyperactivity disorder in Netherlands (PO) before December 2016